By Business/Source
Currency:USD
2026/Q2
Stock NameRevenueRatio
Parasiticides698M28.28%
Vaccines521M21.11%
Dermatology398M16.13%
Anti-infectives244M9.89%
Pain and sedation217M8.79%
Other pharmaceuticals168M6.81%
Animal health diagnostics123M4.98%
Other non-pharmaceuticals70M2.84%
Contract manufacturing & human health29M1.18%
View all
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States (US)5.1B53.84%
Other1.02B10.73%
Other Emerging Markets913M9.64%
Other Developed Markets641M6.77%
Brazil393M4.15%
Australia329M3.48%
United Kingdom325M3.43%
Canada290M3.06%
Germany236M2.49%
China227M2.40%
View all